WithdrawnPHASE1, PHASE2NCT02524639
Sirolimus for the Treatment of Hyperinsulinism
Studying Congenital isolated hyperinsulinism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Hospital of Philadelphia
- Principal Investigator
- Diva De Leon, MD, MDChildren's Hospital of Philadelphia
- Intervention
- Sirolimus(drug)
- Eligibility
- All sexes
- Timeline
- 2015 – 2018
Study locations (1)
- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02524639 on ClinicalTrials.gov